| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
30,283 |
25,479 |
$16.41M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
46,127 |
39,252 |
$13.69M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
39,771 |
35,042 |
$8.52M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
22,351 |
18,839 |
$3.34M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
56,407 |
16,768 |
$2.44M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,448 |
2,313 |
$1.86M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,457 |
7,470 |
$1.65M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,805 |
2,628 |
$1.13M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
19,690 |
15,744 |
$969K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14,221 |
11,981 |
$949K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,805 |
7,381 |
$847K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,955 |
5,184 |
$814K |
| 71046 |
Radiologic examination, chest; 2 views |
13,996 |
12,598 |
$789K |
| 97010 |
|
23,796 |
9,032 |
$749K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,397 |
12,335 |
$699K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,355 |
4,195 |
$663K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,342 |
4,889 |
$660K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,831 |
2,653 |
$632K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,361 |
1,212 |
$623K |
| 71045 |
Radiologic examination, chest; single view |
10,266 |
9,098 |
$557K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
743 |
713 |
$537K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
919 |
841 |
$493K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,405 |
4,211 |
$481K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,297 |
2,952 |
$466K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,735 |
6,851 |
$456K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,119 |
4,488 |
$417K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,658 |
2,380 |
$396K |
| 62323 |
|
1,115 |
1,042 |
$389K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
734 |
696 |
$343K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,311 |
3,097 |
$336K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,947 |
2,664 |
$318K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,415 |
3,117 |
$314K |
| 97035 |
|
6,853 |
2,915 |
$280K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,597 |
748 |
$264K |
| 97161 |
|
5,080 |
4,710 |
$263K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,852 |
1,680 |
$254K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,558 |
2,367 |
$239K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,660 |
879 |
$236K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
10,864 |
9,157 |
$232K |
| 94060 |
|
1,551 |
1,447 |
$225K |
| 76830 |
Ultrasound, transvaginal |
2,193 |
2,039 |
$222K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,193 |
1,083 |
$156K |
| 77065 |
Tomosynthesis, mammo |
1,346 |
1,219 |
$145K |
| 77066 |
Tomosynthesis, mammo |
1,161 |
1,091 |
$135K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
11,667 |
5,078 |
$132K |
| 76642 |
|
2,077 |
1,941 |
$129K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,038 |
928 |
$125K |
| 90791 |
Psychiatric diagnostic evaluation |
3,430 |
2,893 |
$122K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,227 |
1,146 |
$115K |
| 93971 |
|
1,750 |
1,590 |
$113K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
655 |
585 |
$112K |
| 72100 |
|
2,988 |
2,787 |
$107K |
| 97165 |
|
1,735 |
1,606 |
$103K |
| 76770 |
|
1,349 |
1,257 |
$98K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
23,722 |
9,053 |
$98K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,845 |
2,615 |
$97K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
430 |
378 |
$96K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,663 |
4,678 |
$94K |
| 76536 |
|
1,304 |
1,242 |
$94K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,255 |
2,767 |
$92K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,440 |
3,849 |
$89K |
| 93017 |
|
2,212 |
1,977 |
$86K |
| 97014 |
|
2,118 |
1,063 |
$80K |
| 97162 |
|
1,408 |
1,301 |
$73K |
| 76801 |
|
684 |
540 |
$70K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,684 |
1,534 |
$68K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,268 |
3,837 |
$64K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,260 |
3,836 |
$64K |
| 97597 |
|
917 |
572 |
$62K |
| 71250 |
|
1,130 |
1,050 |
$57K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,537 |
3,395 |
$52K |
| 73562 |
|
3,436 |
3,179 |
$51K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,402 |
1,240 |
$50K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,617 |
2,908 |
$47K |
| 86900 |
|
2,992 |
2,584 |
$44K |
| 73030 |
|
2,859 |
2,583 |
$44K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,445 |
1,048 |
$43K |
| 72110 |
|
603 |
562 |
$41K |
| 90837 |
Psychotherapy, 53 minutes with patient |
509 |
270 |
$40K |
| 74018 |
|
1,846 |
1,646 |
$40K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
348 |
310 |
$38K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,977 |
1,702 |
$38K |
| 74183 |
|
190 |
178 |
$37K |
| 97012 |
|
840 |
352 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
23,781 |
20,102 |
$37K |
| 0011A |
|
1,031 |
979 |
$32K |
| 0012A |
|
914 |
883 |
$31K |
| 73630 |
|
3,086 |
2,839 |
$31K |
| 73130 |
|
2,504 |
2,286 |
$31K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,084 |
1,001 |
$30K |
| 73564 |
|
766 |
705 |
$30K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
257 |
235 |
$30K |
| 73610 |
|
2,763 |
2,522 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
809 |
742 |
$29K |
| 76641 |
|
374 |
346 |
$29K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
97 |
85 |
$27K |
| 73110 |
|
1,908 |
1,715 |
$25K |
| 73502 |
|
1,856 |
1,565 |
$25K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
60 |
58 |
$24K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
316 |
305 |
$24K |
| 59025 |
Fetal non-stress test |
165 |
55 |
$22K |
| 99233 |
Prolong inpt eval add15 m |
764 |
429 |
$20K |
| 71271 |
|
198 |
190 |
$17K |
| 73221 |
|
94 |
86 |
$17K |
| 95811 |
|
26 |
26 |
$17K |
| 70496 |
|
143 |
123 |
$16K |
| 86780 |
|
1,435 |
1,294 |
$16K |
| 72141 |
|
117 |
106 |
$16K |
| 90832 |
Psychotherapy, 30 minutes with patient |
740 |
279 |
$16K |
| 70486 |
|
417 |
380 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
50,618 |
39,120 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,573 |
1,458 |
$14K |
| 97116 |
|
1,802 |
1,052 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,072 |
8,450 |
$12K |
| 72040 |
|
314 |
300 |
$12K |
| 0002A |
|
362 |
349 |
$12K |
| 0001A |
|
370 |
354 |
$12K |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
297 |
284 |
$11K |
| 99223 |
Prolong inpt eval add15 m |
226 |
176 |
$9K |
| 73140 |
|
883 |
783 |
$9K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
393 |
369 |
$9K |
| 74220 |
|
78 |
77 |
$8K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
841 |
776 |
$8K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
19,943 |
16,827 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
77 |
75 |
$7K |
| 97535 |
Self-care/home management training, each 15 minutes |
474 |
381 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
153 |
147 |
$7K |
| 99205 |
Prolong outpt/office vis |
111 |
107 |
$6K |
| 0064A |
|
160 |
158 |
$6K |
| 90834 |
Psychotherapy, 45 minutes with patient |
148 |
62 |
$6K |
| 72070 |
|
155 |
144 |
$6K |
| 93970 |
|
47 |
45 |
$6K |
| 72050 |
|
68 |
68 |
$5K |
| 73700 |
|
97 |
89 |
$5K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
262 |
109 |
$5K |
| 99236 |
Prolong inpt eval add15 m |
51 |
49 |
$5K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
301 |
235 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
17,122 |
13,427 |
$4K |
| 10060 |
|
27 |
24 |
$4K |
| 0004A |
|
119 |
118 |
$4K |
| 96367 |
|
169 |
126 |
$4K |
| 94726 |
|
1,253 |
1,167 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
259 |
235 |
$4K |
| 73080 |
|
467 |
430 |
$4K |
| 93225 |
|
85 |
82 |
$4K |
| 99215 |
Prolong outpt/office vis |
201 |
135 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
111 |
109 |
$3K |
| G0378 |
Hospital observation service, per hour |
7,260 |
4,435 |
$3K |
| 76981 |
|
86 |
83 |
$3K |
| 81025 |
|
15,039 |
13,047 |
$3K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
27 |
27 |
$3K |
| 90686 |
|
279 |
245 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
40 |
39 |
$3K |
| 70491 |
|
27 |
24 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,534 |
1,446 |
$3K |
| 77080 |
|
29 |
29 |
$3K |
| 84702 |
|
1,392 |
1,109 |
$3K |
| 80053 |
Comprehensive metabolic panel |
25,394 |
21,307 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
97 |
86 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
10,112 |
8,212 |
$3K |
| 76970 |
|
36 |
32 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,511 |
5,729 |
$3K |
| 96417 |
|
59 |
36 |
$2K |
| 86803 |
|
612 |
554 |
$2K |
| 94618 |
|
161 |
147 |
$2K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
314 |
156 |
$2K |
| 94660 |
|
71 |
52 |
$2K |
| 36430 |
|
13 |
12 |
$2K |
| 93296 |
|
132 |
126 |
$2K |
| 73590 |
|
264 |
227 |
$2K |
| 84703 |
|
2,655 |
2,395 |
$2K |
| 87340 |
|
621 |
561 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,361 |
2,139 |
$2K |
| 87077 |
|
3,823 |
3,440 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
132 |
99 |
$2K |
| 87081 |
|
4,364 |
4,064 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
20,938 |
17,115 |
$2K |
| 85027 |
|
1,071 |
931 |
$1K |
| 87070 |
|
2,049 |
1,852 |
$1K |
| 93270 |
|
62 |
55 |
$1K |
| 97166 |
|
18 |
18 |
$1K |
| 95806 |
|
12 |
12 |
$1K |
| 96415 |
|
19 |
12 |
$1K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
496 |
310 |
$1K |
| 76000 |
|
15 |
12 |
$984.52 |
| 90674 |
|
49 |
46 |
$913.90 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,177 |
5,257 |
$870.34 |
| 0031A |
|
27 |
24 |
$840.00 |
| 87205 |
|
1,987 |
1,710 |
$805.20 |
| 0054A |
|
22 |
22 |
$760.00 |
| 72131 |
|
48 |
36 |
$719.24 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
136 |
55 |
$718.50 |
| 97032 |
|
22 |
17 |
$715.27 |
| 71101 |
|
149 |
138 |
$692.58 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,569 |
5,178 |
$662.67 |
| 87186 |
|
2,267 |
2,014 |
$654.68 |
| 99219 |
|
38 |
24 |
$628.91 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
12 |
$617.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
784 |
715 |
$585.48 |
| 72170 |
|
13 |
13 |
$581.41 |
| 81003 |
|
23,522 |
20,198 |
$548.03 |
| 88142 |
|
77 |
62 |
$518.04 |
| 76870 |
|
13 |
13 |
$494.80 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
176 |
143 |
$486.29 |
| 12001 |
|
396 |
379 |
$399.14 |
| 85610 |
|
7,970 |
5,396 |
$373.08 |
| 93880 |
|
12 |
12 |
$350.13 |
| 83880 |
|
3,468 |
2,980 |
$298.46 |
| 90715 |
|
2,474 |
2,225 |
$283.82 |
| 86850 |
|
2,787 |
2,425 |
$270.68 |
| 80076 |
|
8,311 |
7,381 |
$269.04 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
292 |
247 |
$263.09 |
| 83735 |
|
8,386 |
6,822 |
$254.63 |
| J3490 |
Unclassified drugs |
170,307 |
54,952 |
$250.96 |
| 86318 |
|
64 |
59 |
$247.20 |
| 84484 |
|
14,654 |
10,198 |
$234.78 |
| 80061 |
Lipid panel |
41 |
39 |
$217.43 |
| 83690 |
|
16,161 |
13,682 |
$204.16 |
| 85379 |
|
3,301 |
2,980 |
$202.00 |
| 70498 |
|
96 |
87 |
$194.21 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,453 |
4,146 |
$164.06 |
| 82105 |
|
13 |
13 |
$160.20 |
| 90734 |
|
16 |
12 |
$143.43 |
| 82962 |
|
17,989 |
10,473 |
$132.42 |
| 86901 |
|
2,993 |
2,584 |
$126.52 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,652 |
1,475 |
$115.64 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
835 |
753 |
$90.00 |
| 82803 |
|
1,381 |
1,106 |
$83.38 |
| 87040 |
|
6,300 |
3,190 |
$73.83 |
| 73090 |
|
54 |
53 |
$67.07 |
| 82950 |
|
14 |
14 |
$63.56 |
| 85652 |
|
1,218 |
1,095 |
$63.54 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
897 |
846 |
$61.90 |
| 86618 |
|
1,819 |
1,646 |
$48.60 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
17 |
17 |
$45.30 |
| 82270 |
|
30 |
25 |
$43.54 |
| 83605 |
|
4,760 |
3,674 |
$39.90 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,472 |
1,366 |
$38.29 |
| 85730 |
|
196 |
182 |
$34.38 |
| 87015 |
|
481 |
426 |
$31.61 |
| 86140 |
|
1,121 |
1,001 |
$29.27 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
28,814 |
20,743 |
$22.72 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
6,675 |
5,432 |
$22.32 |
| 82550 |
|
4,118 |
3,292 |
$18.92 |
| 86666 |
|
451 |
227 |
$18.56 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
20 |
13 |
$16.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,151 |
12,578 |
$15.50 |
| J2785 |
Injection, regadenoson, 0.1 mg |
983 |
878 |
$13.60 |
| 87207 |
|
563 |
385 |
$13.33 |
| 96376 |
|
3,329 |
2,474 |
$12.99 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
45 |
41 |
$12.60 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15,032 |
12,270 |
$12.31 |
| 87400 |
|
3,526 |
3,246 |
$11.45 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
10,277 |
8,636 |
$10.31 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,444 |
2,550 |
$8.31 |
| 82010 |
|
649 |
554 |
$7.21 |
| 84132 |
|
831 |
702 |
$4.76 |
| 86308 |
|
77 |
69 |
$4.57 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
492 |
415 |
$4.31 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12,462 |
10,944 |
$4.13 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,394 |
3,540 |
$4.09 |
| J1630 |
Injection, haloperidol, up to 5 mg |
851 |
681 |
$3.60 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,957 |
2,559 |
$2.41 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
370 |
315 |
$2.13 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
365 |
311 |
$2.10 |
| G0008 |
Administration of influenza virus vaccine |
156 |
147 |
$2.00 |
| J2060 |
Injection, lorazepam, 2 mg |
3,005 |
2,381 |
$1.74 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
570 |
295 |
$1.34 |
| J1790 |
Injection, droperidol, up to 5 mg |
906 |
754 |
$1.33 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,495 |
2,838 |
$1.00 |
| J1836 |
Injection, metronidazole, 10 mg |
56 |
40 |
$1.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
2,329 |
1,993 |
$1.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,818 |
2,224 |
$0.94 |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,264 |
1,964 |
$0.31 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
755 |
610 |
$0.17 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
28 |
24 |
$0.17 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
27 |
24 |
$0.16 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,954 |
3,336 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,618 |
1,441 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,604 |
2,008 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
2,242 |
1,967 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
8,882 |
7,314 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
588 |
518 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
1,965 |
830 |
$0.00 |
| 91305 |
|
22 |
22 |
$0.00 |
| 91301 |
|
1,827 |
1,719 |
$0.00 |
| 82077 |
|
614 |
557 |
$0.00 |
| 87807 |
|
497 |
471 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
38 |
29 |
$0.00 |
| 87468 |
|
154 |
141 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,027 |
3,187 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
32 |
27 |
$0.00 |
| 12002 |
|
83 |
80 |
$0.00 |
| 86762 |
|
31 |
26 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
195 |
187 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
59 |
52 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
82 |
68 |
$0.00 |
| C1767 |
Generator, neurostimulator (implantable), non-rechargeable |
17 |
17 |
$0.00 |
| 86617 |
|
47 |
44 |
$0.00 |
| 87484 |
|
154 |
141 |
$0.00 |
| A6022 |
Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each |
262 |
103 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
244 |
196 |
$0.00 |
| 88304 |
|
12 |
12 |
$0.00 |
| 87808 |
|
42 |
39 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
24 |
13 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
165 |
140 |
$0.00 |
| 96368 |
|
18 |
13 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
36 |
24 |
$0.00 |
| 91303 |
|
26 |
24 |
$0.00 |
| 0352U |
|
36 |
34 |
$0.00 |
| 90839 |
|
97 |
81 |
$0.00 |
| 91306 |
|
159 |
157 |
$0.00 |
| A4217 |
Sterile water/saline, 500 ml |
73 |
61 |
$0.00 |
| 87184 |
|
14 |
14 |
$0.00 |
| 88342 |
|
12 |
12 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
16 |
13 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
26 |
13 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
14 |
12 |
$0.00 |
| 88312 |
|
2,008 |
1,883 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,705 |
1,575 |
$0.00 |
| 94729 |
|
1,305 |
1,216 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,752 |
1,595 |
$0.00 |
| 91300 |
|
861 |
796 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,928 |
1,580 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
569 |
509 |
$0.00 |
| 84295 |
|
691 |
586 |
$0.00 |
| 80143 |
|
81 |
71 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
125 |
60 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
659 |
615 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
675 |
464 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,936 |
2,185 |
$0.00 |
| 29125 |
|
124 |
116 |
$0.00 |
| 84145 |
|
122 |
103 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,262 |
7,750 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
298 |
282 |
$0.00 |
| 12011 |
|
66 |
62 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
360 |
329 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
195 |
152 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
103 |
83 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
168 |
139 |
$0.00 |
| 80164 |
|
28 |
24 |
$0.00 |
| 80179 |
|
65 |
57 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
12 |
12 |
$0.00 |
| 82140 |
|
12 |
12 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
101 |
50 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
65 |
53 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
30 |
28 |
$0.00 |
| 87469 |
|
19 |
16 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
15 |
12 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
12 |
$0.00 |